Abstract
Background: The reported results of the Optetrak posterior stabilized total knee prosthesis, which is a modification of the Insall-Burstein knee prosthesis, are inconsistent. We determined whether the design changes of this posterior stabilized fixed-bearing knee prosthesis have achieved their intended objectives at minimum 10-year follow-up. Furthermore, we intended to delineate the specific features to which we attribute to the good outcomes of these Optetrak knee prosthesis. Methods: These were 131 patients (mean age, 68.1 years). The mean follow-up was 10.4 years (range, 11-12 years). The patients were assessed clinically and radiographically with rating systems of the Knee Society. In addition, Western Ontario and McMaster Universities Osteoarthritis (WOMAC) questionnaire, UCLA (University of California at Los Angeles) activity score were determined preoperatively and at each follow-up. Findings: The mean Knee Society knee score was 91 points (range, 70-100 points) at the final follow-up. The mean WOMAC score was 15 points (range, 4-56 points), and the mean UCLA activity score was 6.2 points (range, 4-8 points) at the final follow-up. No knee had an aseptic loosening of the components or osteolysis. The predicted implant survival at 10.4 years was 99% as the end point of any reoperation. Conclusions: The findings of the present 10.4-year clinical study suggest that Optetrak posterior stabilized fixedbearing cemented prosthesis obtained favorable clinical and radiographic results.
Highlights
The ultimate goals of total knee arthroplasty (TKA) are pain relief, restoration of knee motion and clinical performance
Increasing efforts have been made over the past half century to improve the clinical results after TKA by refining their designs
We determined whether the design changes of Optetrak posterior stabilized fixed-bearing knee prosthesis have achieved their intended objectives at minimum 10-year follow-up
Summary
The ultimate goals of total knee arthroplasty (TKA) are pain relief, restoration of knee motion and clinical performance. Robinson et al [2] reported that survival rate of the fixed-bearing prosthesis was 98% at a mean 11.6 years follow-up. We determined whether the design changes of Optetrak posterior stabilized fixed-bearing knee prosthesis have achieved their intended objectives at minimum 10-year follow-up.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of Clinical & Experimental Orthopaedics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.